Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.420
+0.070 (2.09%)
At close: Aug 13, 2025, 4:00 PM
3.420
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:42 AM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $589.65 million as of August 14, 2025. Its market cap has decreased by -50.31% in one year.
Market Cap
589.65M
Enterprise Value
-32.94M
1-Year Change
-50.31%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $589.65M, a decrease of -80.57%. That is a compound annual growth rate of -27.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 577.58M | -16.25% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 577.15B |
| Johnson & Johnson | 418.76B |
| AbbVie | 348.37B |
| UnitedHealth Group | 231.45B |
| Abbott Laboratories | 229.46B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |